Home > Income Statement > BIOCON

BIOCON
Revenue

    Back to Income Statement
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹16,927 Cr₹15,262 Cr₹14,756 Cr₹11,174 Cr₹8,184 Cr

What is the latest Revenue of BIOCON ?

The latest Revenue ratio of BIOCON is ₹16,927 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹16,927 Cr
Mar2025₹15,262 Cr
Mar2024₹14,756 Cr
Mar2023₹11,174 Cr
Mar2022₹8,184 Cr

How is Revenue of BIOCON Trending?

Years Revenue % Change
Mar2026 ₹16,927 Cr
10.91
Mar2025 ₹15,262 Cr
3.43
Mar2024 ₹14,756 Cr
32.05
Mar2023 ₹11,174 Cr
36.54
Mar2022 ₹8,184 Cr -

Compare Revenue of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹71,063.1 Cr -1% 4.9% 8.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹473,509.0 Cr 0.6% 6% 14.6% Stock Analytics
DIVIS LABORATORIES ₹196,881.0 Cr 1.2% 10.5% 7.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,832.0 Cr -0.4% 11% 40.8% Stock Analytics
CIPLA ₹113,894.0 Cr -1.6% -2.1% -4.8% Stock Analytics
DR REDDYS LABORATORIES ₹96,062.8 Cr -4.6% -14.8% -8.4% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-1%

4.9%

8.7%

SENSEX

-1.1%

-0.2%

-6.6%


You may also like the below Video Courses